Search research articles
Contact Us
Filters
Showing results (451-460 of 664) with videos related to
Page
of 67
Sort By:
Journal of the Endocrine Society
|
December 12, 2018
Reproductive and Behavior Dysfunction Induced by Maternal Androgen Exposure and Obesity Is Likely Not Gut Microbiome-Mediated
Lisa Lindheim, Maria Manti, Romina Fornes, et al.
BMC Endocrine Disorders
|
April 9, 2009
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism
Stefan Pilz, Andreas Tomaschitz, Vinzenz Stepan, et al.
Scientific Reports
|
October 30, 2019
Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke
Simon Fandler-Höfler, Christian Enzinger, Markus Kneihsl, et al.
Bone
|
April 26, 2016
Direct comparison of regulators of calcification between bone and vessels in humans
N Schweighofer, A Aigelsreiter, O Trummer, et al.
Journal of Clinical Medicine
|
July 14, 2023
AMH in Males: Effects of Body Size and Composition on Serum AMH Levels
Veronika Tandl, Christoph Haudum, Katharina Eberhard, et al.
Frontiers in Medicine
|
July 10, 2023
Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosis
Philipp Jud, Andreas Meinitzer, Heimo Strohmaier, et al.
European Journal of Endocrinology
|
February 6, 2019
Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society
Paul Lips, Kevin D Cashman, Christel Lamberg-Allardt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 28, 2007
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis
Steven Boonen, Fernando Marin, Barbara Obermayer-Pietsch, et al.
Bone
|
August 10, 2017
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
Elena Tsourdi, Bente Langdahl, Martine Cohen-Solal, et al.
Journal of Viral Hepatitis
|
December 17, 2013
Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels
M Mandorfer, T Reiberger, B A Payer, et al.
Page
of 67
Search research articles
Search
Showing results (451-460 of 664) with videos related to
Sort By:
Page
of 67
Journal of the Endocrine Society
|
December 12, 2018
Reproductive and Behavior Dysfunction Induced by Maternal Androgen Exposure and Obesity Is Likely Not Gut Microbiome-Mediated
Lisa Lindheim, Maria Manti, Romina Fornes, et al.
BMC Endocrine Disorders
|
April 9, 2009
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism
Stefan Pilz, Andreas Tomaschitz, Vinzenz Stepan, et al.
Scientific Reports
|
October 30, 2019
Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke
Simon Fandler-Höfler, Christian Enzinger, Markus Kneihsl, et al.
Bone
|
April 26, 2016
Direct comparison of regulators of calcification between bone and vessels in humans
N Schweighofer, A Aigelsreiter, O Trummer, et al.
Journal of Clinical Medicine
|
July 14, 2023
AMH in Males: Effects of Body Size and Composition on Serum AMH Levels
Veronika Tandl, Christoph Haudum, Katharina Eberhard, et al.
Frontiers in Medicine
|
July 10, 2023
Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosis
Philipp Jud, Andreas Meinitzer, Heimo Strohmaier, et al.
European Journal of Endocrinology
|
February 6, 2019
Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society
Paul Lips, Kevin D Cashman, Christel Lamberg-Allardt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 28, 2007
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis
Steven Boonen, Fernando Marin, Barbara Obermayer-Pietsch, et al.
Bone
|
August 10, 2017
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
Elena Tsourdi, Bente Langdahl, Martine Cohen-Solal, et al.
Journal of Viral Hepatitis
|
December 17, 2013
Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels
M Mandorfer, T Reiberger, B A Payer, et al.
Page
of 67